Antihypertensive drugs that have targets the reninangiotensin system, does pulmonary ACE2 levels, thus favoring a greater entry of SARS COV-2?

  • Funded by Ministerio de Ciencia, Tecnología e Innovación [Ministry of Science, Technology and Innovation] (MINCYT)
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $6,125.21
  • Funder

    Ministerio de Ciencia, Tecnología e Innovación [Ministry of Science, Technology and Innovation] (MINCYT)
  • Principal Investigator

    MARIELA GIRONACCI
  • Research Location

    Argentina
  • Lead Research Institution

    Universidad de Buenos Aires
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract